Genetic variants associated with breast-cancer risk.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

4 citing papers in PubMed.

1. Association study of germline variants in CCNB1 and CDK1 with breast cancer susceptibility, progression, and survival among Chinese Han women.PloS one · 2013
   Trial
2. Impact on breast cancer susceptibility and clinicopathological traits of common genetic polymorphisms inOncology letters · 2022
   Article
3. Next-generation sequencing for inherited breast cancer risk: counseling through the complexity.Current oncology reports · 2014
   Review
4. Association of germline variation in CCNE1 and CDK2 with breast cancer risk, progression and survival among Chinese Han women.PloS one · 2012
   Article

Corrections and comments

• Comment on
  Genetic variants associated with breast-cancer risk: comprehensive research synopsis, meta-analysis, and epidemiological evidence.2011
• Erratum issued

Authors and funding

1 author.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as